Affordable Access

The interaction between prognostic and pharmacodynamic biomarkers.

British Journal of Cancer
Nature Publishing Group
Publication Date
  • Medicine
  • Pharmacology


Background:Interactions between prognostic and pharmacodynamic (PD) biomarkers have received little attention.Methods:Prognostic and PD utilities were assessed with linear mixed-effects models using published data on repeated measurements of circulating caspase-cleaved (ctCK18) and total (tCK18) cytokeratin 18, in 57 patients with metastatic colorectal cancer undergoing chemotherapy.Results:The model for tCK18 (but not cCK18) separated the prognostic/PD interaction from the pure prognostic effect, illustrating the principle of dual prognostic and PD characteristics for a given biomarker.Conclusion:These models provide the framework for the analysis and interpretation of longitudinal data to detect prognostic/PD biomarker interactions.British Journal of Cancer advance online publication, 3 September 2013; doi:10.1038/bjc.2013.527

There are no comments yet on this publication. Be the first to share your thoughts.